Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
2 hours ago
2 hours ago
touchSYMPOSIUM for touchRESPIRATORY
Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.
Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC.
Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation
Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC
Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection
Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/
2 hours ago
2 hours ago
touchSYMPOSIUM for touchONCOLOGY
Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.
Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC.
Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation
Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC
Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection
Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/
Friday Apr 11, 2025
Friday Apr 11, 2025
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.
The experts
- Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
- Dr Christina Lampe, University of Giessen, Giessen, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit: touchneurologyime.org/
Friday Apr 11, 2025
Friday Apr 11, 2025
touchPANEL DISCUSSION for touchENDOCRINOLOGY
Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes.
The experts
- Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA
- Dr Christina Lampe, University of Giessen, Giessen, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Chiesi USA, Inc.
The activity is jointly provided by USF Health and touchIME.
For further information visit: touchendocrinologyime.org/
Monday Apr 07, 2025
Monday Apr 07, 2025
touchIN CONVERSATION for touchONCOLOGY
Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms.
The experts
- Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France
- Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/
Wednesday Apr 02, 2025
Wednesday Apr 02, 2025
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients.
The experts
- Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany
- Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France
- Prof. Alessandro Vannucchi – University of Florence, Florence, Italy
This touchPODCAST is for HCPs outside of the UK and USA only.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchhaematologyime.org/
Monday Mar 31, 2025
Monday Mar 31, 2025
Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Monday Mar 31, 2025
Monday Mar 31, 2025
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
- Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Monday Mar 31, 2025
Monday Mar 31, 2025
Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer.
The multidisciplinary team
- Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France
- Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchONCOLOGY.com
Monday Mar 31, 2025
Monday Mar 31, 2025
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice.
The expert
- Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from Bayer Consumer Care AG.
The activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases